News
“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.
Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug ...
For people who constantly think about what they are going to eat meal to meal, their food noise goes down significantly’ ...
The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...
Muscle loss is common among those on GLP-1 receptor agonists — like semaglutide or liraglutide — which mimic gut hormones to ...
10d
Green Matters on MSNA Study Has Been Launched After Weight Loss Drug Users Report Pancreas ProblemsIf you or your family and friends take some weight loss medications, you'll want to read this. Some users are reporting ...
The proceedings follow a PIL seeking a ban on sale of weight loss drugs that are still undergoing clinical trials ...
The Delhi High Court on Tuesday disposed of a public interest litigation (PIL) raising alarm over the off-label and ...
Since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been hundreds of reported cases of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results